The UK-based fish treatments giant said its buying the entire share capital of Norwegian data technology firm, Videntis, to support its long term strategy.
Benchmark, the aquaculture health, advanced nutrition, and genetics business, announced in a press release that it has agreed to acquire the entire issued share capital of the Oslo-based, Videntis, a provider of data technology to aquaculture and agriculture producers for an initial consideration of £150,000 and a total consideration of up to £300,000.
“Videntis’ technology enables producers to have real-time data and feedback on feed efficiency, welfare and product quality,” Benchmark said. And it that buying it played into their “strategy of bringing together technology and biology to improve yield, quality and profitability for its customers.”
Malcolm Pye, Chief Executive of Benchmark said:
“We have worked with Videntis for a number of years. Videntis’ IP and expertise support our strategy of combining biology and technology to benefit our customers. Data technology is an increasingly important tool to maximise yield and to manage biological challenges. Combined with Benchmark’s products it allows us to offer an integrated solution to our clients.”
